CBIO — Crescent Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Crescent Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	90.3	47.9	41.8	10.7	213
Net Total Accounts Receivable
Net Total Receivables	0.001	0.144	0.176	0.137	19.3
Prepaid Expenses
Total Current Assets	90.8	50.7	43.8	11.1	237
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.95	0.994	0.768	0	2.31
Other Long Term Assets
Total Assets	94.3	51.8	45.3	11.1	240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.8	8.88	6.84	5.78	36.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.7	8.88	6.9	5.78	37.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	81.6	42.9	38.4	5.31	203
Total Liabilities & Shareholders' Equity	94.3	51.8	45.3	11.1	240
Total Common Shares Outstanding